NASDAQ: SSKN
Strata Skin Sciences Inc Stock Ownership - Who owns Strata Skin Sciences?

Insider buying vs selling

Have Strata Skin Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Accelmed Partners LP10% Owner2024-07-15230,573$3.14
$724.00kBuy
URI GeigerDirector2024-07-15230,573$3.14
$724.00kBuy
Dolev RafaeliChief Executive Officer2024-07-1519,100$3.14
$59.97kBuy

1 of 1

SSKN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SSKN insiders and whales buy or sell their stock.

SSKN Shareholders

What type of owners hold Strata Skin Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Accelmed Growth Partners LP1,450.14%60,487,545$136.10MInsider
URI Geiger323.14%13,478,872$30.33MInsider
Accelmed Partners LP138.27%5,767,340$12.98MInsider
Bonanza Capital Ltd112.59%4,696,474$10.57MInsider
22nw LP84.31%3,516,898$7.91MInsider
Bonanza Master Fund Ltd75.79%3,161,400$7.11MInsider
Broadfin Capital LLC61.10%2,548,594$5.73MInsider
Broadfin Healthcare Master Fund Ltd24.17%1,008,297$2.27MInsider
Austin W. Greenhouse David M. Marxe18.26%761,726$1.71MInsider
Dan W. Lufkin18.06%753,398$1.70MInsider

1 of 3

SSKN vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SSKN1.23%98.77%Net Buying
CODX17.34%29.41%Net SellingNet Selling
WOK0.70%0.00%
PAVM5.94%94.06%
SINT3.49%96.51%Net BuyingNet Buying

Strata Skin Sciences Stock Ownership FAQ

Who owns Strata Skin Sciences?

Strata Skin Sciences (NASDAQ: SSKN) is owned by 29.51% institutional shareholders, 2,374.76% Strata Skin Sciences insiders, and 0.00% retail investors. Accelmed Growth Partners LP is the largest individual Strata Skin Sciences shareholder, owning 60.49M shares representing 1,450.14% of the company. Accelmed Growth Partners LP's Strata Skin Sciences shares are currently valued at $138.52M.

If you're new to stock investing, here's how to buy Strata Skin Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.